RNTX
Rein Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Rein Therapeutics, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No reported quarters.
No open-interest data.
Bar = avg |move| to ±6% · tick = ±4.6% avg day · ×base = |move| ÷ ±4.6% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -0.10 | — |
| Q1 FY26 | — | -0.19 | — |
| Q3 FY25 | — | -0.21 | — |
Source: filed financials
Expected move
No implied move.
0.66
+0.02 · +3.45%
post 0.67 +1.95%
No linked exposure.
Largest filed tie
—
No filed income statement.